Skip to main content
Clinical Trials/NCT05302713
NCT05302713
Withdrawn
Not Applicable

Evaluating Changes in Quality of Life and Epigenetic Methylation From Antiorbital Ionic Calcium in Older Adults With Chronic Conditions

National University of Natural Medicine1 site in 1 countryApril 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
National University of Natural Medicine
Locations
1
Primary Endpoint
Rate of Biological Aging
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to determine the mechanistic effects of an ionic calcium supplement in adults with atrial fibrillation, osteoarthritis, and hypertension. The study aims to determine if ionic calcium supplementation affects quality of life, rate of biological aging, bone densitometry, and blood biomarkers of bone metabolism over a six month period compared to non-ionic calcium comparator supplement.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
December 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ryan Bradley

Director of Research

National University of Natural Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Rate of Biological Aging

Time Frame: Week 24

Dunedin Pace of Aging Calculated objective measure of the rate of epigenetic aging

Patient Reported Outcomes Measurement Information system-29 Physical Function Sub-domain

Time Frame: Week 24

Quality of Life

Secondary Outcomes

  • Changes in Cognition(Week 24)
  • Changes in Systolic and Diastolic Blood Pressure(Week 24)
  • Changes in Mood(Week 24)
  • Changes in Anxiety(Week 24)
  • Changes in Pain and Disability(Week 24)

Study Sites (1)

Loading locations...

Similar Trials